No significant differences in response rate or progression free survival were observed.
Renal cell carcinoma survival after nephrectomy.
Changes in future survival probability over time.
Bianchi m 1 becker a hansen j trinh qd tian z abdollah f briganti a shariat sf perrotte p montorsi f karakiewicz pi sun m.
The median overall survival was 18 4 months in the sunitinib alone group and 13 9 months in the nephrectomy sunitinib group.
Survival rates for renal cell carcinoma are sometimes based on the percentage.
Adverse events were as anticipated in each group.
Abstract background cytoreductive nephrectomy has been the standard of care in metastatic renal cell carcinoma for 20 years supported by randomized trials and large retrospective studies.
Organ confined disease pathologic stage pt1 2 confers the best prognosis with 5 year cancer specific survival rates after nephrectomy ranging from 71 to 97.
Conditional survival after nephrectomy for renal cell carcinoma rcc.